Navigation Links
pfuturbo DNA Polymerase:,,,A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning

e amplicon generated by PfuTurbo DNA polymerase was also purified using the StrataPrep PCR kit method prior to the ligation reaction. The CAM amplicons were ligated to the PCR-Script vector, and the products were transformed into Epicurian Coli XL1-Blue MRF Kan supercompetent cells according to instructions in the PCR-Script Amp SK(+) cloning kit manual. The transformation mixtures were plated on LB ampicillin (50 g/ml) plates containing 0.5mM IPTG and 40 g/ml X-gal. Following overnight incubation at 37C, recombinant (white) and nonrecombinant (blue) colonies were counted. White colonies containing the putative insert were replica plated onto LB plates containing chloramphenicol (35 g/ml) to determine the percentage of CAM-resistant positives.

Figure 1

The mean percentage of recombinant clones per plate (white colony number divided by blue colony number multiplied by 100) and the mean percentage of white colonies that were also CAM-resistant are presented in Figure 1: PfuTurbo DNA polymerase produced CAM amplicons cloned with high efficiency (85%). Amplicons generated from Taq DNA polymerase were also cloned with greater than 85% efficiency, if the amplicons were polished prior to ligation to the PCR Script vector. The cloning efficiency of Taq-generated product was less than 10% in these experiments if no polishing reaction was performed (data not shown).

Conclusions

PfuTurbo DNA polymerase is a high-performance, high-fidelity enzyme formulation ideal for generating blunt-end PCR amplicons that are easily cloned with high efficiency using the PCR-Script cloning kit. Amplicons generated with Taq DNA polymerase not only require polishing prior to ligation to the PCR Script vector but also possess six-fold greater errors. When com
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
2. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
3. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
4. High-Fidelity PCR with a Novel Polymerase Mixture
5. The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature
6. Comparing Fidelity and Performance of Proofreading PCR Enzymes
7. Greater Amplification Specificity with New Hot Start PCR Enzyme
8. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
9. Improve Amplification Specificity with Hot Start PCR Enzyme
10. Choice of RT-PCR Enzymes
11. Properties of PCR Enzymes
Post Your Comments:
(Date:7/24/2008)...wswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ... tender,offer by its direct wholly-owned subsidiar...of Third Wave Technologies, Inc. (Nasdaq: TWTI ) ...equent offering period expired at 12:00 midnight, ...he initial tender offer period expired,at 12:00 mi...
(Date:7/24/2008)...wswire/ -- Cara Therapeutics, Inc.,announced today... funding,to its original $24 million Series C fina...ed by new investor, Devon Park Bioventures, and in...revious investors participating,in the round inclu...ational,Corporation and Wistar Morris. In conjunct...
(Date:7/24/2008)...- United,Therapeutics Corpo...ll,release its 2008 second quarter financial resul... 2008., United Therapeutics will host a half-hour...0 a.m. Eastern Time. The teleconference is accessi...callers dialing,1-706-679-8129. A rebroadcast of t...
(Date:7/23/2008)... Original Warrant Amount by an Additional ...24 /- Cell Therapeutics, In...ingle institutional investor,has agreed to purchas...ble,Senior Notes due 2011, with a conversion price...roximately 28.2 million shares of common stock wit...
Breaking Biology Technology:Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3
...nformation officer and vice provost for informatio...on has been narrowed to three Midwestern finalist...nalists are Ronald D. Kraemer, deputy CIO and asso...mation Technology (DoIT); Kathy Pletcher, associat...Green Bay ; and Deanna M. Raineri, associate dean ...
...ow they view the Viasys Healthcare,s NeuroCare G... excited about the growth potential of the Fitchbu...ement between Cardinal Health and Viasys Healthcar... the NeuroCare Group, for $1.5 billion, pending ap..., ,In a conference call with investors, several to...
... Workforce Development will make $850,000 in stat...otes high-tech skills training. , ,The funding, pa...e, will support the Emerging Industries Skills Par...between businesses and schools so that current and...market. , ,Grants will be offered to businesses, i...
...from the term cloning, even with the controversial...lieves in time the technique he developed to creat... in the development of human therapies, just as hu... biologist with the Scottish Center for Regenerat...in Madison to lecture on the science of that cloni...
Other Biology Technology:Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 2Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 3Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance 4
(Date:7/24/2008)...omise to make it easier for people with impaired v...harper distance vision. Schepens Eye Research Inst...innovative glasses over earlier devices in an arti... Biomedical Optics , mailed in print form to subs...ral advantages," says the inventor of the glasses,...
(Date:7/24/2008)...e University College of Medicine, Hershey, Pennsyl...od, a clinically important immune response modifie... dependent on the Opioid Growth Factor (OGF)-OGF r...y, reported in the August 08 issue of Experimenta...o a widely used drug that may lead to development ...
(Date:7/24/2008)...8) A multi-institutional team of researchers, inc...edical School, have developed a powerful tool for ...ill allow researchers to generate synthetic enzyme... inactivation or repair. , The potential for disc...f the Arnold and Mabel Beckman Center for Transpos...
(Date:7/24/2008)... is currently burning through a study area where p...ears ago. Managers used data and analysis from the...the planning, analysis, and implementation of trea...ive., The Gotchen LSR, lies on the east slope of... 15,000 acres of the Mount Adams Ranger District o...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Consortium develops new method to manipulate genetic material 2Landscape study may offer solutions for fire managers 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 1Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 1363 3UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 1UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 2UT Southwestern plastic surgeons deploy new carbon dioxide based fractional laser 11748 3Cigarette after Valentine snuggle deadlier for some 2187 1Cigarette after Valentine snuggle deadlier for some 2187 2Cigarette after Valentine snuggle deadlier for some 2187 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 1Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 2Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 4Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 5Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 6
...mpoo to paints and varnishes can create self-sanit...public buildings that continue killing germs for m...state consortium of high school students and retir...s.com, 10 students from New York, Texas and Virgin...d railroader from Virginia to report their researc...
...d" on the international deep sea floor ?need prote...ns a new report from the Japan-based United Nation...AS). , Increasingly recognized as important to hum... deep sea resources are now more accessible and vu...ploration technology, the report says. , Known as...
...lts more accurate than PSA , Researchers at the U...have identified a panel of 22 biomarkers that toge...e cancer than the current prostate specific antige...22 issue of the New England Journal of Medicine. ,...31 prostate cancer patients prior to surgery, and ...
...g been thought to be important only to translate a...horses. But new evidence shows that tiny bits of R... roles in normal biology and in the development of... that production of these tiny RNAs, known as micr... and in certain tissues, but no one had been able ...
Other Biology News:Shampoo detergent added to paint makes surfaces self-sterilizing 2Clear rules needed to govern deep sea bioprospecting: UNU 2Clear rules needed to govern deep sea bioprospecting: UNU 3Clear rules needed to govern deep sea bioprospecting: UNU 4Clear rules needed to govern deep sea bioprospecting: UNU 5U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Once given 'no respect,' cells' tiny RNAS take driver's seat 2Once given 'no respect,' cells' tiny RNAS take driver's seat 3
...ne/PAD: ZMD.471. Immunogen: Synthetic peptide der...hilin-1. Specificity: Specific for the junctophil...s: mouse brain and skeletal muscle homogenates fro...lications: Western blotting Immunohistochemistry(f...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody
HSV 1 IgM
...typus Contact Printing Kit contains choice of Prin...1000 Angsroms of Gold over Ti adhesion layer, 1 si...r TI adhesion layer, or 3 plain glass slides), PDM... of 100 / 200 micron squares or 100 um x 10 mm or ...
Biology Products: